Baker McKenzie and Shearman & Sterling advised Aztiq on the deal.
Aztiq executed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, via a consortium formed with co-investor Innobic (Asia) Company Limited from its existing shareholders for USD475 million.
The financing for the acquisition was provided by a syndicate of banks including BNP Paribas, Far Eastern International Bank and Shinhan Investment Corp.
The alliance between Aztiq and Innobic, and with the completion of the AEMH deal, will create a global pharmaceuticals enterprise with extensive resources, networks and reach all over the world.
The Baker McKenzie team was led by Singapore-based M&A partner Kay Moon (Picture), and included Robert Wright, Timon Chiong, Joanne Chong, Liang Jun Ong and Charlie Wong from the M&A team across Singapore and Hong Kong; and Stephen Crosswell, Tom Jenkins, Lip Hang Poh and Vivian Tsang from the antitrust/merger control team in Hong Kong and Singapore; and Alex Chiang and Hao-Ray Hu from the capital markets/finance team in Taipei.
Shearman & Sterling advised Aztiq on the financing arrangements with Gary Hamp, Tim Waterson, Harry Poland, Elizabeth Wood, and Carmen Yuen.
Involved fees earner: Alex Chiang – Baker McKenzie; Timon Chiong – Baker McKenzie; Joanne Chong – Baker McKenzie; Stephen Crosswell – Baker McKenzie; Hao-Ray Hu – Baker McKenzie; Tom Jenkins – Baker McKenzie; Liang Jun Ong – Baker McKenzie; Kay Moon – Baker McKenzie; Lip Hang Poh – Baker McKenzie; Vivian Tsang – Baker McKenzie; Charlie Wong – Baker McKenzie; Robert Wright – Baker McKenzie; Gary Hamp – Shearman & Sterling; Harry Poland – Shearman & Sterling; Tim Waterson – Shearman & Sterling; Elizabeth Wood – Shearman & Sterling; Carmen Yuen – Shearman & Sterling;